ORBIMED ADVISORS LLC Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$5.5B
Holdings
112
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (112 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SVASINOVAC BIOTECH LTD | 2,718,735 | $340.0B | 6227.15% | |
| 2 | LLYELI LILLY & CO | 360,800 | $280.7B | 5140.84% | |
| 3 | EWTXEDGEWISE THERAPEUTICS INC | 15,021,721 | $274.0B | 5018.28% | |
| 4 | BSXBOSTON SCIENTIFIC CORP | 3,273,000 | $224.2B | 4105.67% | |
| 5 | ISRGINTUITIVE SURGICAL INC | 493,100 | $196.8B | 3604.26% | |
| 6 | BIIBBIOGEN INC | 900,900 | $194.3B | 3557.92% | |
| 7 | MRKMERCK & CO INC | 1,316,000 | $173.6B | 3180.36% | |
| 8 | JANXJANUX THERAPEUTICS INC | 4,275,553 | $161.0B | 2948.27% | |
| 9 | ELVNENLIVEN THERAPEUTICS INC | 8,998,338 | $158.3B | 2898.94% | |
| 10 | THCTENET HEALTHCARE CORP | 1,173,300 | $123.3B | 2258.73% | |
| 11 | BMRNBIOMARIN PHARMACEUTICAL INC | 1,278,500 | $111.7B | 2045.15% | |
| 12 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,680,496 | $106.3B | 1946.07% | |
| 13 | IRONDISC MEDICINE INC | 1,702,237 | $106.0B | 1941.06% | |
| 14 | SYKSTRYKER CORPORATION | 269,000 | $96.3B | 1763.15% | |
| 15 | SPRYARS PHARMACEUTICALS INC | 9,240,887 | $94.4B | 1729.72% | |
| 16 | SRPTSAREPTA THERAPEUTICS INC | 697,500 | $90.3B | 1653.83% | |
| 17 | ISIIONIS PHARMACEUTICALS INC | 2,013,033 | $87.3B | 1598.27% | |
| 18 | ELVELEVANCE HEALTH INC | 168,100 | $87.2B | 1596.47% | |
| 19 | XTNTXTANT MED HLDGS INC | 73,114,592 | $85.5B | 1566.75% | |
| 20 | EVHEVOLENT HEALTH INC | 2,605,615 | $85.4B | 1564.81% | |
| 21 | APLSAPELLIS PHARMACEUTICALS INC | 1,447,800 | $85.1B | 1558.65% | Call |
| 22 | SWTXSPRINGWORKS THERAPEUTICS INC | 1,707,331 | $84.0B | 1539.11% | |
| 23 | KROSKEROS THERAPEUTICS INC | 1,268,734 | $84.0B | 1538.29% | |
| 24 | NTRANATERA INC | 899,431 | $82.3B | 1506.64% | |
| 25 | TMOTHERMO FISHER SCIENTIFIC INC | 132,000 | $76.7B | 1405.13% | |
| 26 | PCVXVAXCYTE INC | 1,066,131 | $72.8B | 1333.85% | |
| 27 | CRNXCRINETICS PHARMACEUTICALS IN | 1,385,000 | $64.8B | 1187.41% | |
| 28 | SRRKSCHOLAR ROCK HLDG CORP | 3,574,632 | $63.5B | 1162.75% | |
| 29 | ARGXARGENX SE | 151,600 | $59.7B | 1093.19% | |
| 30 | ICLRICON PLC | 174,100 | $58.5B | 1071.23% | |
| 31 | NBIXNEUROCRINE BIOSCIENCES INC | 423,100 | $58.4B | 1068.76% | |
| 32 | SIBNSI-BONE INC | 3,424,521 | $56.1B | 1026.74% | Call |
| 33 | VRNAVERONA PHARMA PLC | 3,398,067 | $54.7B | 1001.38% | |
| 34 | THRDTHIRD HARMONIC BIO INC | 5,779,071 | $54.6B | 999.17% | |
| 35 | AVBPARRIVENT BIOPHARMA INC | 3,027,328 | $54.1B | 990.27% | |
| 36 | NPCENEUROPACE INC | 4,003,967 | $52.9B | 968.00% | |
| 37 | PRLDPRELUDE THERAPEUTICS INC | 10,909,256 | $51.7B | 947.07% | |
| 38 | VRTXVERTEX PHARMACEUTICALS INC | 122,700 | $51.3B | 939.38% | |
| 39 | TERNTERNS PHARMACEUTICALS INC | 7,619,135 | $50.0B | 915.42% | |
| 40 | CYTKCYTOKINETICS INC | 682,700 | $47.9B | 876.64% | |
| 41 | APGEAPOGEE THERAPEUTICS INC | 718,901 | $47.8B | 874.93% | |
| 42 | CMPXCOMPASS THERAPEUTICS INC | 22,362,850 | $44.3B | 810.97% | |
| 43 | GONGERON CORP | 12,893,611 | $42.5B | 779.29% | |
| 44 | SNDXSYNDAX PHARMACEUTICALS INC | 1,749,000 | $41.6B | 762.39% | |
| 45 | QTTBQ32 BIO INC | 2,252,987 | $38.4B | 703.14% | |
| 46 | ESPRESPERION THERAPEUTICS INC NE | 13,708,731 | $36.7B | 672.89% | |
| 47 | UNHUNITEDHEALTH GROUP INC | 70,000 | $34.6B | 634.24% | |
| 48 | RYTMRHYTHM PHARMACEUTICALS INC | 704,842 | $30.5B | 559.36% | |
| 49 | ALXOALX ONCOLOGY HLDGS INC | 2,717,970 | $30.3B | 555.05% | |
| 50 | VERAVERA THERAPEUTICS INC | 675,872 | $29.1B | 533.77% | |
| 51 | PRAXPRAXIS PRECISION MEDICINES I | 460,512 | $28.1B | 514.66% | |
| 52 | HRTXHERON THERAPEUTICS INC | 10,111,550 | $28.0B | 512.99% | |
| 53 | SCPHSCPHARMACEUTICALS INC | 5,559,528 | $27.9B | 511.15% | |
| 54 | SLRNACELYRIN INC | 4,001,711 | $27.0B | 494.72% | |
| 55 | IMAPRELUDE THERAPEUTICS INC | 5,680,186 | $26.9B | 493.12% | |
| 56 | TORCEURADICET BIO INC | 11,447,140 | $26.9B | 492.69% | |
| 57 | MLYSMINERALYS THERAPEUTICS INC | 2,021,424 | $26.1B | 477.96% | |
| 58 | RNAAVIDITY BIOSCIENCES INC | 994,100 | $25.4B | 464.65% | |
| 59 | XENEXENON PHARMACEUTICALS INC | 550,000 | $23.7B | 433.66% | |
| 60 | REGNREGENERON PHARMACEUTICALS | 22,800 | $21.9B | 401.92% | |
| 61 | —KINNATE BIOPHARMA INC | 8,009,729 | $21.3B | 390.22% | |
| 62 | ARWRARROWHEAD PHARMACEUTICALS IN | 739,651 | $21.2B | 387.44% | |
| 63 | NMRANEUMORA THERAPEUTICS INC. | 1,500,000 | $20.6B | 377.75% | |
| 64 | DYNDYNE THERAPEUTICS INC | 708,400 | $20.1B | 368.34% | |
| 65 | MORFMORPHIC HLDG INC | 558,500 | $19.7B | 360.06% | |
| 66 | DC4DEXCOM INC | 140,300 | $19.5B | 356.41% | |
| 67 | ABCLABCELLERA BIOLOGICS INC | 4,180,768 | $18.9B | 346.87% | |
| 68 | IMTXIMMATICS N.V | 1,769,708 | $18.6B | 340.66% | |
| 69 | VSTMVERASTEM INC | 1,529,115 | $18.0B | 330.47% | |
| 70 | AMGNAMGEN INC | 63,400 | $18.0B | 330.15% | |
| 71 | AVTEAEROVATE THERAPEUTICS INC | 565,374 | $16.7B | 306.19% | |
| 72 | TELATELA BIO INC | 2,835,542 | $16.1B | 294.46% | |
| 73 | RPTXREPARE THERAPEUTICS INC | 3,322,488 | $15.6B | 286.61% | |
| 74 | PASGPASSAGE BIO INC | 10,124,576 | $13.7B | 250.33% | |
| 75 | TYRATYRA BIOSCIENCES INC | 768,638 | $12.6B | 230.87% | |
| 76 | CRVSCORVUS PHARMACEUTICALS INC | 6,943,654 | $12.4B | 226.37% | |
| 77 | IVVDINVIVYD INC | 2,690,300 | $11.9B | 218.77% | |
| 78 | PMVPPMV PHARMACEUTICALS INC | 6,475,291 | $11.0B | 201.61% | |
| 79 | VTYXVENTYX BIOSCIENCES INC | 1,870,456 | $10.3B | 188.42% | |
| 80 | FATEFATE THERAPEUTICS INC | 1,355,352 | $9.9B | 182.20% | |
| 81 | ASNSUSDX4 PHARMACEUTICALS INC | 7,133,515 | $9.9B | 181.61% | |
| 82 | EXASEXACT SCIENCES CORP | 140,400 | $9.7B | 177.58% | |
| 83 | IMAIKENA ONCOLOGY INC | 6,368,587 | $9.0B | 165.63% | |
| 84 | CGEMCULLINAN ONCOLOGY INC | 517,606 | $8.8B | 161.54% | |
| 85 | NKTXNKARTA INC | 800,000 | $8.6B | 158.39% | |
| 86 | LXRXLEXICON PHARMACEUTICALS INC | 3,542,000 | $8.5B | 155.69% | |
| 87 | TXG10X GENOMICS INC | 225,200 | $8.5B | 154.80% | |
| 88 | —TURNSTONE BIOLOGICS CORP | 3,099,265 | $8.1B | 148.72% | |
| 89 | ISREURPERSPECTIVE THERAPEUTICS INC | 6,505,800 | $7.7B | 141.79% | |
| 90 | CTMXCYTOMX THERAPEUTICS INC | 3,544,578 | $7.7B | 141.52% | |
| 91 | AM6AMICUS THERAPEUTICS INC | 570,300 | $6.7B | 123.04% | |
| 92 | KRYSKRYSTAL BIOTECH INC | 37,166 | $6.6B | 121.12% | |
| 93 | VIRVIR BIOTECHNOLOGY INC | 640,000 | $6.5B | 118.74% | |
| 94 | APLMAPOLLOMICS INC | 8,565,456 | $6.4B | 117.66% | |
| 95 | NSPRINSPIREMD INC | 2,133,405 | $5.1B | 92.61% | |
| 96 | —IKENA ONCOLOGY INC | 3,539,358 | $5.0B | 92.05% | |
| 97 | —ELEVATION ONCOLOGY INC | 941,275 | $4.8B | 88.44% | |
| 98 | PGNYPROGYNY INC | 113,300 | $4.3B | 79.17% | |
| 99 | ORICORIC PHARMACEUTICALS INC | 287,100 | $3.9B | 72.30% | |
| 100 | MISTMILESTONE PHARMACEUTICALS IN | 2,000,000 | $3.6B | 65.57% |
Page 1 of 2Next